GUIDELINES FOR ABSTRACT SUBMISSION

We welcome submissions in Oncology related topics.

All abstracts should be submitted and presented in clear English with accurate grammar and spelling.

Abstract Structure

1-Abstract title:

The title is limited to 20 words and should be in bold, sentence case (no unnecessary capitalization) with no full stop at the end and no underlining. Please avoid abbreviations in the title. Abbreviations may be used in the text if they are defined when first used.

2-Authors and co-authors' details:

• -First name, middle initials (if required), and surname with no full stop at the end. Underline the name of the corresponding author. A comma should separate author names. Where authors are from a number of different institutions, the appropriate institution number from the affiliation list should be given as a superscript number immediately after each author's name. An asterisk* should be used to link the corresponding author with their email address, if being included.
• - Affiliations: Affiliations should include department, institute, town and country. Where there are multiple affiliations, each should be listed as a separate paragraph.

3- Abstract layout:

• Abstracts must be submitted with the below headings, which should be typed in bold with no colon at the end. Each heading should be in a separate paragraph as follows:
• - Objectives
• - Methods
• - Results
• - Conclusions
• - For Case report abstracts: Background, Case report, Conclusion.
• - Key words: List a maximum of 5 key words.
• - Acknowledgements: Brief acknowledgements may be included and should be placed after Conclusions.

4- Main text

• Should be not more than 400 words.

5- Font face

• :Times New Roman, and size: 11 points. Please use single line spacing.

6- Graphs & Images

• :A maximum of 3 images can be included per abstract. The maximum file size of each graph/image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. Images can be uploaded in JPG, GIF or PNG format. Graphs/images should be numbered with a short, descriptive title.

7-Tables

• :A maximum of 3 tables of up to 10 rows x 10 columns can be included per abstract. Tables should be numbered (e.g. Table 1) with a short, descriptive title. Table characters are not included in the cumulative character count.

8- Please avoid the use of references in the abstract.

9- The abstracts should be submitted in MS Word format (DOC or DOCX).

CONSENTS & ETHICS

Please write a statement for each of the following points after the abstract’s main text:

• 1-The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission.
• 2- Any abstract that includes identifiable information about individual patients must include a Consent to Publish statement.
• 3-Conflict of Interest & Ethical Approval - The presenting author must declare that an ethical approval had been received for the study (if relevant). A statement detailing this, including the name of the ethics committee and the reference number where appropriate, must appear in the abstract reporting such research. If the study has been granted an exemption from requiring ethics approval, this should also be detailed in the abstract (including the name of the ethics committee that granted the exemption). - The authors must declare if they have any conflict of interest to disclose.
• 4-Trial registration - If the abstract reports the results of a controlled health care intervention, the trial registry, along with the identifying number should be listed at the end of the abstract.

Abstracts’ Reviewing & Selection Process

• Abstracts should represent the original scientific data performed by the author. The abstracts’ reviewing committee will review all submitted abstracts within two weeks after its receipt.
• If a revision is required, the revised abstract must be sent back within five days.
• Accepted abstracts: Authors will receive a confirmation email providing the hall name and the abstract number which will be the same number displayed on the board in the posters’ hallway.

Abstract Submitter Responsibilities

• The abstracts’ content is the responsibility of their authors. The organizers reserve the right to reject abstracts that are not written in English, out of the scope of the conference, do not meet basic standards of scientific quality, or do not adhere to conventional standards and common ethics.
• The accepted abstract should be presented at the conference by the author or, at least, by one of the co-authors. If this is not possible, please withdraw your abstract as early as possible. Without early withdrawal, abstracts not presented at the conference are identified as no-shows.
• Abstracts may not be edited/updated after final submission. You are welcome to bring an updated abstract onsite with you.
• The deadline for abstracts submission is April 10th 2025.